Breaking News, Collaborations & Alliances

Takeda Partners with Biological E. to Accelerate Access to Dengue Vaccine

Will enhance manufacturing capabilities to ensure a sustainable global supply of the vaccine.

Author Image

By: Charlie Sternberg

Associate Editor

Takeda has tapped Biological E. Limited, a vaccines and biologics company in India, to manufacture Takeda’s dengue vaccine, TAK-003.   The partnership marks a crucial step in the fight against the global public health threat of dengue fever, aligning with the disease-specific target set by the World Health Organization (WHO) to achieve zero case-fatality rate due to dengue by 2030.   The partnership will enhance manufacturing capabilities to ensure a sustainable global supply of the va...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters